BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8900553)

  • 1. Methotrexate and misoprostol for early abortion.
    Schaff EA; Eisinger SH; Franks P; Kim SS
    Fam Med; 1996 Mar; 28(3):198-203. PubMed ID: 8900553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate. A single agent for early abortion.
    Schaff EA; Penmetsa U; Eisinger SH; Franks P
    J Reprod Med; 1997 Jan; 42(1):56-60. PubMed ID: 9018647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA; Stadalius LS; Eisinger SH; Franks P
    J Fam Pract; 1997 Apr; 44(4):353-60. PubMed ID: 9108832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K; Fong YF; Dong F
    BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined methotrexate and misoprostol for early induced abortion.
    Schaff EA; Eisinger SH; Franks P; Kim SS
    Arch Fam Med; 1995 Sep; 4(9):774-9. PubMed ID: 7647943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abortion induced with methotrexate and misoprostol.
    Wiebe ER
    CMAJ; 1996 Jan; 154(2):165-70. PubMed ID: 8548705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K; Pekhlivanov B; Amaliev I
    Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of telephone follow-up after medical abortion.
    Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
    Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
    Singh KC; Ummat S; Rajaram S; Goel N
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):495-8. PubMed ID: 16401215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol.
    Creinin MD
    Contraception; 1997 Dec; 56(6):367-71. PubMed ID: 9494770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
    Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
    Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
    Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.